381
Participants
Start Date
November 30, 2007
Primary Completion Date
July 31, 2009
Study Completion Date
May 31, 2010
Sinovial® (syringe containing sodium hyaluronate solution)
2 mL 0.8% sodium hyaluronate (16 mg) solution. 3 intra-articular injections once-a-week.
Synvisc® ( syringe containing Hylan G-F 20 solution)
2 mL 0.8% Hylan G-F 20 (16 mg) solution. 3 intra-articular injections once-a-week.
Department of Rheumatology and Institute of Physical Medicine - Zurich University, Zurich
Institute of Rheumatology, Prague
Centrum léčby pohybového aparátu spol. s.r.o., Prague
Unità Operativa di Reumatologia - Istituto Ortopedico Gaetano Pini, Milan
Ospedale Privato Accreditato Nigrisoli, Bologna
Orthopädische Universitätsklinik und Poliklinik der RWTH Aachen, Aachen
Sezione Dipartimentale a valenza provinciale di Reumatologia - AzUSL 8, Arezzo
ARTHROMED s.r.o., Pardubice
"Unità Operativa di Reumatologia - Az. Ospedaliera Universitaria Senese - Policlinico Le Scotte", Siena
Medicina e Traumatologia dello Sport - AzUSL 2 Lucca, Lucca
Rheumatology Unit Santa Chiara Hospital, Pisa
Interni hemato-onkologická klinika, Fakultní nemocnice, Brno - Bohunice
University Hospital Centre Bois-Guillaume, Bois-Guillaume
Orthopädische Praxis, Stockach
University Hospital Centre of Limoges - Rheumatology Service, Limoges
Nova clinic, Biberach an der Riss
F.D. Roosevelt's University Hospital, Banská Bystrica
Romjan s.r.o., Bratislava
National Institute of Rheumatic Diseases, Piešťany
Rheumatology Clinic, Reumaglobal s.r.o, Trnava
Lead Sponsor
IBSA Institut Biochimique SA
INDUSTRY